 |
New medicines are made possible by participation in clinical trials, and patient recruitment is often the rate limiting step in bringing new therapies to market. In rare diseases, this problem is further amplified. Research has shown that patients are likely to participate in clinical trials when they are aware of trial opportunities and are empowered with knowledge to optimize their engagement experiences. In this webinar, learn how Medidata is improving access to, and optimizing experiences in, clinical trials through its Patient Insights Program and myMedidata Patient Registries. |
